NASDAQ:NLNK (3/18/2020, 8:00:05 PM)
0.89
-0.13 (-12.75%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 35.49 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.42 | ||
| P/tB | N/A | ||
| EV/EBITDA | 1.27 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -44.42% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | -4822.01% | ||
| PM (TTM) | -4592.84% | ||
| GM | N/A | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.98 | ||
| Quick Ratio | 7.98 | ||
| Altman-Z | -4.15 |
ChartMill assigns a fundamental rating of 2 / 10 to NLNK.
ChartMill assigns a valuation rating of 3 / 10 to Newlink Genetics Cor (NLNK). This can be considered as Overvalued.
Newlink Genetics Cor (NLNK) has a profitability rating of 1 / 10.
The financial health rating of Newlink Genetics Cor (NLNK) is 4 / 10.